Research ReportSomatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ42 oligomers via a metalloproteinase-dependent mechanism
Keywords: Aβ; amyloid protein; SSTR; somatostatin receptor subtype; APP; amyloid precursor protein; AD; Alzheimer's disease; Phosphoramidon; NNC 26-9100; Somatostatin receptor subtype-4; Amyloid-beta oligomer;